中文名称 |
英文名称 |
CAS号 |
化学式 |
结构式图片 |
PVM/MA共聚物乙酯 |
Gantrez ES 225 |
25087-06-3 |
C9H14O5 |
|
PVM/MA共聚物 |
vorasidenib |
1644545-52-7 |
C14H13ClF6N6 |
|
PTP抑制剂IV |
C,C,C-Trifluoro-N-[4-(1-methyl-1-{4-[1-methyl-1-(4-trifluoromethanesulfonylamino-phenyl)-ethyl]-phenyl}-ethyl)-phenyl]-methanesulfonamide |
329317-98-8 |
C26H26F6N2O4S2 |
|
PTH-天冬酰胺 |
D,L-asparagine N-phenylthiohydantoin |
5624-08-8 |
C11H11N3O2S |
|
PTH-DL-α-氨基异丁酸 |
5,5-Dimethyl-3-phenyl-2-thiohydantoin |
21083-30-7 |
C11H12N2OS |
|
PTH-DL-2-氨基丁酸 |
5-ethyl-3-phenyl-2-thioxoimidazolidin-4-one |
66256-32-4 |
C11H12N2OS |
|
PTCBI(顺反混合物) |
Benzimidazole perylene |
79534-91-1 |
C27H18N2 |
|
PTC-209抑制剂 |
PTC-209 |
315704-66-6 |
C17H13Br2N5OS |
|
PSS-联苯基乙烯基硅氧基-七环戊基取代物 |
Pss-(diphenylvinylsilyloxy)heptaclopent& |
312693-49-5 |
C49H76O13Si9 |
|
PSS-甲苯基乙烯基硅氧基-七环戊基取代物 |
Pss-methylphenylvinylsilyloxy-heptacycl& |
312693-48-4 |
C44H74O13Si9 |
|
PSS-烯丙基-七环戊基取代 |
PSS-Allyl-Heptacyclopentyl substituted |
205131-81-3 |
C38H68O12Si8 |
|
PSS-烯丙基-七异丁基取代 |
PSS-Allyl-Heptaisobutyl substituted |
351003-00-4 |
C31H68O12Si8 |
|
PSS-氯丙基-异丁基取代 |
(3-chloropropyl)hepta(isobutyl)octasilsesquioxane |
480438-84-4 |
C31H69ClO12Si8 |
|
PSS-八[2-(氯二甲基硅烷基)乙基]取代 |
octa(chlorodimethylsilylethyl)silsesquioxane |
243146-51-2 |
C32H80Cl8O12Si16 |
|
PSS-八(2-二氯甲基硅基乙基)取代 |
1,3,5,7,11,13,15-octakis[2-(dichloromethylsilyl)ethyl]pentacyclo[9.5.1.1<sup>3,9</sup>.1<sup>5,15</sup>.1<sup>7,13</sup>]octasiloxane |
314727-18-9 |
C24H56Cl16O12Si16 |
|
PSS-[2-(3-环己烯)乙基]-七环戊基取代 |
Pss-(2-(3-cyclohexen-1-YL)ethyl)heptacy& |
307496-19-1 |
C43H76O12Si8 |
|
PSS-[2-(3,4-环氧环己基)乙基]-取代七异丁基 |
1,3,5,7,9,11,13-Heptakis(2-methylpropyl)-15-[2-(7-oxabicyclo[4.1.0]heptan-3-yl)ethyl]-2,4,6,8,10,12,14,16,17,18,19,20-dodecaoxa-1,3,5,7,9,11,13,15-octasilapentacyclo[9.5.1.13,9.15,15.17,13]icosane |
445379-56-6 |
C36H76O13Si8 |
|
PSS-[2-(3,4-环氧树脂环己基)乙基]-七环戊基取代 |
1,3,5,7,9,11,13-heptacyclopentyl-15-[2-(7-oxabicyclo[4.1.0]heptan-3-yl)ethyl]-2,4,6,8,10,12,14,16,17,18,19,20-dodecaoxa-1,3,5,7,9,11,13,15-octasilapentacyclo[9.5.1.13,9.15,15.17,13]icosane |
307496-16-8 |
C43H76O13Si8 |
|
PSS-[1-(乙基十一酸)]-七环戊基取代 |
Pss-(1-(ethyl undecanoate))-heptacyclop& |
308103-65-3 |
C48H88O14Si8 |
|
PSS-Octa(2-三氯甲硅烷基乙基)取代 |
1,3,5,7,11,13,15-octakis[2-(trichlorosilyl)ethyl]pentacyclo[9.5.1.1<sup>3,9</sup>.1<sup>5,15</sup>.1<sup>7,13</sup>]octasiloxane |
214675-88-4 |
C16H32Cl24O12Si16 |
|
PSS-(4-(氯甲基)苯基)-七环戊基取代 |
Pss-(4-(chloromethyl)phenyl))-heptacycl& |
307496-35-1 |
C42H69ClO12Si8 |
|
PSS-(3-缩水甘油基)丙氧基-取代七异丁基 |
Pss-(3-glycidyl)propoxy-heptaisobutyl S& |
444315-17-7 |
C34H74O14Si8 |
|
PSS-(3-环己基)-七环戊基取代 |
Pss-(3-cyclohexen-1-YL)-heptacyclopenty& |
307496-29-3 |
C41H72O12Si8 |
|
PSS-(3-巯基)丙基-七异丁基取代 |
1-(3-mercapto)propyl-3,5,7,9,11,13,15-isobutylpentacyclo[9.5.1.1<sup>3,9</sup>.1<sup>5,15</sup>.1<sup>7,13</sup>]octasiloxane |
480438-85-5 |
C31H70O12SSi8 |
|
PSS-(2-(反式-3,4-环己二醇)乙基)-七异丁基取代 |
Pss-(2-(trans-3 4-cyclohexanediol)ethyl& |
480439-48-3 |
C36H78O14Si8 |
|
PSS-(1-丙基异丁烯酸)-七异丁基取代 |
Pss-(1-propylmethacrylate)-heptaisobuty& |
307531-94-8 |
C35H74O14Si8 |
|
PSS-(1-(甲基丙酸))-七环戊基取代 |
methyl 3-(3,5,7,9,11,13,15-heptacyclopentyl-2,4,6,8,10,12,14,16,17,18,19,20-dodecaoxa-1,3,5,7,9,11,13,15-octasilapentacyclo[9.5.1.13,9.15,15.17,13]icosan-1-yl)propanoate |
308103-64-2 |
C39H70O14Si8 |
|
PSN375963盐酸盐 |
PSN375963 |
388575-52-8 |
C17H23N3O |
|
PRT-060318(PRT318)中间体 |
2-chloro-4-(3-methylanilino)pyrimidine-5-carboxylic acid |
227449-26-5 |
C12H10ClN3O2 |
|
PROTOPORPHYRIN營XCOBALTCHLORIDE |
Co(iii) protoporphyrin ix chloride |
102601-60-5 |
C34H32ClCoN4O4 |
|
PROTACBET结合部分2 |
(S)-4-(4-chlorophenyl)-6-(2-methoxy-2-oxoethyl)-3,9-dimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-2-carboxylic acid |
916493-82-8 |
C20H17ClN4O4S |
|
PRL-3抑制剂 |
5-[[5-Bromo-2-[(2-bromophenyl)methoxy]phenyl]methylene]-2-thioxo-4-thiazolidinone |
893449-38-2 |
C17H11Br2NO2S2 |
|
PR171关键中间体IV |
(S)-methyl 2-((S)-2-tert.butoxycarbonyIamino-4-phenylbutanamido-4-methylpentanamido)-3-phenylpropanoate |
868539-96-2 |
C31H43N3O6 |
|
PPIase-Parvulin抑制剂 |
1,3,6,8-tetrahydro-1,3,6,8-tetraoxo-benzo[lmn][3,8]phenanthroline-2,7-diacetic acid 2,7-diethyl ester |
64005-90-9 |
C22H18N2O8 |
|
PPG-6-山梨醇聚醚-245 |
PPG-6-Sorbeth-245 |
56449-05-9 |
C36H74O18 |
|
PPG-2肉豆蔻醇醚丙酸酯 |
PPG-2 myristyl ether propionate |
111497-87-1 |
C23H46O4 |
|
PPG-2甲醚 |
Dipropylenglykol-monomethylether |
13429-07-7 |
C7H16O3 |
|
PPG-26油酸酯 |
3-hydroxypropyl (E)-octadec-9-enoate |
31394-71-5 |
C21H40O3 |
|
PPADS四钠盐 |
Ppads |
149017-66-3 |
C14H14N3O12PS2 |
|
PPACKII,三氟乙酸盐 |
Phenylalanyl-phenylalanyl-arginine chloromethyl ketone |
74392-49-7 |
C25H33ClN6O3 |
|
POSS-十二苯基 |
Heptacyclo(11.11.1.13,9.15,21.17,19.111,17.115,23)dodecasiloxane, 1,3,5,7,9,11,13,15,17,19,21,23-dodecaphenyl- |
18923-59-6 |
C72H60O18Si12 |
|
PORCN酶活性和WNT抑制剂(WNT-C59) |
2-(4-(2-methylpyridin-4-yl)phenyl)-N-(4-(pyridin-3-yl)phenyl)acetamide |
1243243-89-1 |
C25H21N3O |
|
POLO-LIKEKINASE1抑制剂 |
GSK461364 |
929095-18-1 |
C27H28F3N5O2S |
|
PND-1186游离态 |
2-(2-(2-methoxy-4-morpholinophenylamino)-5-(trifluoromethyl)pyridin-4-ylamino)-N-methylbenzamide |
1061353-68-1 |
C25H26F3N5O3 |
|
PNA-胸腺嘧啶单体 |
2-(N-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)ethyl)-2-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamido)acetic acid |
169396-92-3 |
C26H26N4O7 |
|
PNA-胞嘧啶单体 |
N-(N-Fmoc-2-aminoethyl)-N-[(N-4-Bhoc-1-cytosyl)acetyl]glycine |
186046-81-1 |
C39H35N5O8 |
|
PLK1抑制剂(RO3280) |
RO3280 |
1062243-51-9 |
C27H35F2N7O3 |
|
PKR抑制剂,阴性对照 |
5-Chloro-3-[(3,5-dichloro-4-hydroxyphenyl)methylidene]-1,3-dihydro-2H-indol-2-one |
852547-30-9 |
C15H8Cl3NO2 |
|
PKR抑制剂(MITAPIVAT) |
N-(4-(4-(cyclopropylmethyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide |
1260075-17-9 |
C24H26N4O3S |
|
PKI-402; 1-[4-[3-乙基-7-(吗啉-4-基)-3H-[1,2,3]三唑并[4,5-d]嘧啶-5-基]苯基]-3-[4-[(4-甲基哌嗪-1-基)羰基]苯基]脲 |
PKI-402 |
1173204-81-3 |
C29H34N10O3 |
|